MedTrace Logo

Single Center, Open Label, Follow up Study in Subjects Who Previously Received Rabies Vaccine as Simulated Post-Exposure Regimen

NCT01067079 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2011-12-30

No results posted yet for this study

Summary

This study will evaluate the immunogenicity of rabies vaccine at 13 months, 3 year and 5 years after initial vaccination, administered in two different post-exposure vaccination schedules

Conditions

  • Rabies

Interventions

OTHER

No vaccine administered; subjects only have blood sampling for immunogenicity

No vaccine administered; subjects only have blood sampling for

Sponsors & Collaborators

  • Novartis Vaccines

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • China

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01067079 on ClinicalTrials.gov